Intervention

candesartan

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions7

Lead sponsors shown4

Clinical trials

5 shown

The Antihypertensives and Vascular, Endothelial and Cognitive Function TrialNCT00605072 · 2008-01-01

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus LercanidipineNCT00564057 · 2007-09-01

DIabetic Retinopathy Candesartan TrialsNCT00252694 · 2001-08-01

DIabetic Retinopathy Candesartan Trials.NCT00252720 · 2001-08-01

Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive DrugsNCT00192803

Common conditions

Hypertension2 Aging1 Cognitive Impairment1 HIV Infections1 NIDDM1 Type 1 Diabetes1 Type 2 Diabetes1

Leading sponsors

AstraZeneca2 Rambam Health Care Campus1 Università degli Studi dell'Insubria1 University of Southern California1

Trial status mix

COMPLETED3

UNKNOWN2

Phase mix

PHASE32

PHASE42

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.